TOP STORIES

• BUSINESS Jump in New Grad Hires Seen with Drug Makers in Japan: 2025 Poll
  April 4, 2025

• REGULATORY Japan Mulls Amendment of GCP Ordinance, Making Single IRBs a Rule
  April 3, 2025

• REGULATORY Japan Picks 14 “Loss” Products as Drugs with Highest Priority for Development
  April 2, 2025

• ORGANIZATION JPMA Renews Call for Social Security Not Reliant on Drug Price Cuts: FY2025 Policy
  April 2, 2025

• COMMENTARY How Will Japan Deal with Expected Cost Spike with Japan-Made Antibiotic APIs?
  April 1, 2025

• REGULATORY Japan Jittery over Mass Layoffs at FDA, though HHS Says Reviewers Won’t Be Affected
  March 31, 2025

• REGULATORY Japan Approves J&J’s Lazcluze, Genmab’s Tivdak, and More
  March 28, 2025

• BUSINESS Kyushu University Offshoot Eyes US Nod for Repositioned ROP Drug Candidate
  March 27, 2025

• BUSINESS J&J Submits Information Disclosure Requests to Japan Govt over Off-Year Revision
  March 26, 2025

• BUSINESS FRONTEO’s AI Engine Can Help Unearth Drug Targets, Predict Odds of Success: CTO
  March 25, 2025

• COMMENTARY Fair or Unfair? PMP Return Applied for First Time in Off-Year Revision
  March 24, 2025

• BUSINESS New BMS Japan Chief Vows Bold Resource Allocation towards Doubling of Sales
  March 21, 2025

• BUSINESS Datroway, Zeposia, and More Meds Now Available in Japan; Zepbound Launch Set for April 11
  March 21, 2025

• REGULATORY US Chamber Raises Japan’s Pharma Policy as Unfair Trade Practice, Prods Federal Govt for Action
  March 19, 2025

• BUSINESS Novartis CEO Touts Plan to Amp Up Japan Investment, Add 50 Jobs for Early Trials
  March 18, 2025

• BUSINESS Jiho Survey Finds Improvement in Price Revision Rates for Generic Players
  March 17, 2025

• BUSINESS KalVista Eyes Japan Debut with World’s 1st Oral On-Demand HAE Drug
  March 14, 2025

• REGULATORY MHLW Panel OKs List of “High-Priority” Vaccines, including Norovirus Jabs
  March 14, 2025

• REGULATORY Zepbound, Qalsody, and More New Drugs Set for Japan Listing on March 19
  March 13, 2025

• BUSINESS More than Half of Drug Makers’ Top 5 Meds See Flat or Positive Revisions: Poll
  March 12, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• …
• Next ›
• 最終 »